Swedish Life Sciences Stock News

OM:ATCO A
OM:ATCO AMachinery

Assessing Atlas Copco (OM:ATCO A) Valuation After Q1 Results And Approved Ordinary And Extra Dividends

Atlas Copco (OM:ATCO A) is back in focus after its first quarter update, which combined fresh earnings data with an approved total dividend of SEK 5.00 per share, split between ordinary and extra distributions. See our latest analysis for Atlas Copco. At a share price of SEK174.2, Atlas Copco has combined a 30 day share price return of 4.72% with a 1 year total shareholder return of 17.37%, suggesting momentum has softened slightly in recent months after a stronger run. If Atlas Copco’s mix...
OM:VIT B
OM:VIT BSoftware

Vitec Software Group (OM:VIT B) Valuation After Strong Q1 Results And Higher Quarterly Dividend

Vitec Software Group (OM:VIT B) has drawn fresh attention after reporting first quarter figures, along with an approved quarterly dividend of SEK 3.68 per share at its April 28, 2026 Annual General Meeting. See our latest analysis for Vitec Software Group. Despite a 1.5% 1 day share price return taking Vitec to SEK254.6, the 1 year total shareholder return of 44.8% decline and 3 year total shareholder return of 53.2% decline point to fading longer term momentum, even as the earnings beat and...
OM:AFRY
OM:AFRYProfessional Services

Is Afry (OM:AFRY) Tweaking Dividends And Share Issuance To Quietly Recast Its Capital Playbook?

Afry AB has released its first-quarter 2026 results, reporting sales of SEK 6,325 million and net income of SEK 240 million, alongside its Annual General Meeting decisions to re-elect the board, confirm Tom Erixon as chairman, approve a SEK 6 dividend, and authorize potential issuance of up to 10% new Class B shares. The combination of slightly lower quarterly earnings and fresh AGM mandates on dividends, executive incentives, and potential share issuance highlights how Afry is balancing...
OM:PNDX B
OM:PNDX BReal Estate

Pandox (OM:PNDX B) One Off SEK2.0b Gain Tests Bullish Earnings Narratives

Pandox (OM:PNDX B) has just opened Q1 2026 reporting with trailing twelve month revenue of about SEK7.5b and basic EPS of SEK16.13, supported by the latest quarterly print from Q4 2025 where revenue was SEK2.1b and EPS came in at SEK8.68. Over recent quarters, revenue has moved from SEK1.90b in Q2 2025 and SEK1.97b in Q3 2025 to SEK2.08b in Q4 2025, while basic EPS has shifted from SEK3.61 to SEK3.25 to SEK8.68 over the same stretch. This sets up this release as a check on how durable the...
OM:EPEN
OM:EPENElectronic

Exploring High Growth Tech Stocks with Global Potential

As global markets navigate a landscape marked by record highs in major U.S. stock indexes and robust retail sales growth, the technology sector continues to capture investor attention with its potential for innovation and expansion. In this context, identifying high-growth tech stocks with global potential involves looking at companies that not only capitalize on the current demand for AI and related technologies but also demonstrate resilience in managing economic uncertainties such as...
OM:HTRO
OM:HTROElectrical

Hexatronic Group (OM:HTRO) Trailing Loss Challenges Bullish Earnings Rebound Narrative

Hexatronic Group (OM:HTRO) opened 2026 with Q1 numbers that underline a tough earnings backdrop, as trailing 12 month data to Q1 2026 shows revenue of SEK 7.5b and a small net loss of SEK 14m, translating into basic EPS of SEK 0.07. Over recent quarters, revenue has sat in a tight band between SEK 1,824m and SEK 1,951m. Quarterly EPS has swung from a loss of SEK 0.59 in Q3 2025 to a profit of SEK 0.52 in Q3 2024, highlighting how sensitive margins are to shifts in profitability. For...
OM:EVO
OM:EVOHospitality

Evolution (OM:EVO) Valuation Check After Q1 2026 Earnings Reset Expectations

Q1 2026 earnings set the tone Evolution (OM:EVO) has drawn fresh investor attention after releasing first quarter 2026 earnings, with sales of €513.04 million and net income of €251.93 million setting a new reference point for the stock. See our latest analysis for Evolution. Since the Q1 2026 results and the recent board appointment on 24 April, Evolution’s 30 day share price return of 11.64% and 90 day gain of 9.50% contrast with a 3 year total shareholder return of negative 47.01%. This...